The world's leading condom producer, Malaysian firm Karex, has signalled that global prices for contraceptives could increase by 20% to 30% if supply chain disruptions stemming from the conflict in Iran persist. The company, which manufactures over five billion units annually for brands like Durex and Trojan, cites soaring shipping costs and critical material shortages as primary drivers.
In an interview with Reuters, Karex CEO Goh Miah Kiat stated the situation is "definitely very fragile" and that the company has "no choice but to transfer the costs right now to the customers." He noted that demand has actually increased as shipping delays have depleted customer inventories, creating a strained market where supply cannot readily meet need.
European and Global Deliveries Delayed
For European and American markets, the logistical impact is severe. Karex reports that shipments now take nearly two months to arrive, with some vessels unable to reach their destinations at all. This disruption directly affects supplies to major European distributors and public health bodies, including the United Kingdom's National Health Service (NHS).
The war's impact on key maritime chokepoints, particularly the Strait of Hormuz, has snarled the flow of petrochemical derivatives essential for production. According to Goh, costs have risen sharply for synthetic rubber, nitrile for non-latex variants, and packaging materials like aluminium foil. Even lubricants such as silicone oil have become more expensive and harder to source.
This comes amid broader warnings from EU officials about prolonged price hikes linked to Middle East instability, highlighting how regional conflicts reverberate through global commodity markets.
Compounding a Pre-existing Shortage
The current crisis exacerbates an existing global condom shortage. This shortfall began after the dismantling of the United States Agency for International Development (USAID), previously the largest bilateral donor to global family planning. USAID had supplied 35% of contraceptives in international supply chains, serving 23 countries.
Countries in Africa and the Middle East, which relied heavily on this aid, have reported severe shortages. Data from the Joint United Nations Programme on HIV/AIDS indicates a 55% decline in male condom distribution in Nigeria between December 2024 and March 2025. Karex also supplies major health organisations like the Global Fund and the United Nations Population Fund, meaning these price and supply pressures will directly impact critical HIV prevention and family planning programmes worldwide.
The situation underscores the fragile nature of global health supply chains, a theme also visible in debates over EU migration policy, where external factors heavily influence internal European security and resource planning.
While Karex states it has sufficient supplies for the next few months and is working to increase output, the confluence of logistical gridlock, material cost inflation, and pre-existing deficits paints a challenging outlook. The episode serves as a stark reminder of how geopolitical instability in one region can directly affect essential health commodity prices and availability across Europe and the globe.
